台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.05
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    586
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/29     後一日»

券商獲利排行 - 2024/03/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.97%13-11440501026.726.726.627.1
  0.93%7.507.53030026.826.8027.1
  0.44%5.4-1.26.733461326.826.826.827.1
  1.18%4.704.71515026.726.7027.1
  1.69%4.504.51010026.626.6027.1
  1.69%4.504.51010026.626.6027.1
  0.74%3.3-0.43.71517226.826.826.627.1
  0.91%2.202.299026.826.8027.1
  0.55%2.2-0.42.61015526.826.826.727.1
  1.31%2.102.166026.726.7027.1
  1.50%20255026.726.7027.1
  1.39%1.801.855026.726.7027.1
  0.84%1.801.868226.826.826.827.1
  1.09%1.701.766026.826.8027.1
  1.27%1.701.755026.726.7027.1
  1.12%1.501.555026.826.8027.1
  0.93%1.501.566026.826.8027.1
  1.31%1.401.444026.726.7027.1
  1.69%1.301.333026.626.6027.1
  1.50%1.201.233026.726.7027.1
  1.12%1.201.244026.826.8027.1
  0.37%1.11.8-0.7-371126.826.626.927.1
  1.31%10133026.726.7027.1
  0.62%11.2-0.2-15626.826.726.927.1
  0.74%10155026.926.9027.1
  1.69%0.900.922026.626.6027.1
  1.69%0.900.922026.626.6027.1
  1.69%0.900.922026.626.6027.1
  1.12%0.900.933026.826.8027.1
  1.60%0.800.822026.626.6027.1
  1.50%0.800.822026.726.7027.1
  1.50%0.800.822026.726.7027.1
  1.50%0.800.822026.726.7027.1
  1.00%0.80.20.623126.826.726.927.1
  1.41%0.700.722026.726.7027.1
  1.31%0.700.722026.726.7027.1
  1.31%0.700.722026.726.7027.1
  1.31%0.700.722026.726.7027.1
  1.22%0.600.622026.726.7027.1
  0.13%0.6-1.31.97191226.726.826.727.1
  0.56%0.60.6004426.826.726.827.1
  1.13%0.60.10.412126.726.626.827.1
  1.12%0.600.622026.826.8027.1
  1.12%0.600.622026.826.8027.1
  0.75%0.600.623126.826.826.827.1
  1.88%0.500.511026.626.6027.1
  0.93%0.50.20.312126.826.726.927.1
  0.93%0.500.522026.826.8027.1
  0.93%0.500.522026.826.8027.1
  0.93%0.500.522026.826.8027.1

券商虧損排行 - 2024/03/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.38%-41.10-41.1-112011226.7026.727.1
  -1.24%-6.60-6.6-2002026.7026.727.1
  -0.89%-50-5-2102126.8026.827.1
  -1.31%-3.50-3.5-1001026.7026.727.1
  -0.62%-2.50-2.5-1501526.9026.927.1
  -1.28%-2.40-2.4-70726.7026.727.1
  -0.98%-2.30-2.4-81926.826.826.827.1
  -1.20%-2.20-2.2-60726.726.926.727.1
  -0.91%-2.20-2.2-90926.8026.827.1
  -1.25%-20-2-60626.7026.727.1
  -0.93%-20-2-70826.827.126.827.1
  -1.15%-1.80-1.8-60626.7026.727.1
  -1.50%-1.60-1.6-40426.7026.727.1
  -1.20%-1.60-1.6-50526.7026.727.1
  -1.12%-1.5-0.1-1.4-41526.726.826.727.1
  -1.37%-1.10-1.1-30326.7026.727.1
  -1.03%-1.10-1.1-40426.8026.827.1
  -0.93%-10-1-40426.8026.827.1
  -0.93%-10-1-40426.8026.827.1
  -0.93%-10-1-40426.8026.827.1
  -1.69%-0.90-0.9-20226.6026.627.1
  -1.69%-0.90-0.9-20226.6026.627.1
  -1.69%-0.90-0.9-20226.6026.627.1
  -1.12%-0.90-0.9-30326.8026.827.1
  -1.06%-0.80-0.8-30326.8026.827.1
  -0.63%-0.80.2-1-41526.826.726.827.1
  -1.00%-0.80-0.8-30326.8026.827.1
  -0.93%-0.70-0.7-30326.8026.827.1
  -1.31%-0.70-0.7-20226.7026.727.1
  -1.31%-0.70-0.7-20226.7026.727.1
  -1.31%-0.70-0.7-20226.7026.727.1
  -1.31%-0.70-0.7-20226.7026.727.1
  -1.22%-0.60-0.6-20226.7026.727.1
  -1.12%-0.60-0.6-20226.8026.827.1
  -1.12%-0.60-0.6-20226.8026.827.1
  -1.03%-0.50-0.5-20226.8026.827.1
  -1.88%-0.50-0.5-10126.6026.627.1
  -0.93%-0.50-0.5-20226.8026.827.1
  -0.93%-0.50-0.5-20226.8026.827.1
  -1.69%-0.40-0.4-10126.6026.627.1
  -1.69%-0.40-0.4-10126.6026.627.1
  -1.69%-0.40-0.4-10126.6026.627.1
  -1.50%-0.40-0.4-10126.7026.727.1
  -1.50%-0.40-0.4-10126.7026.727.1
  -1.50%-0.40-0.4-10126.7026.727.1
  -1.50%-0.40-0.4-10126.7026.727.1
  -1.50%-0.40-0.4-10126.7026.727.1
  -0.66%-0.40-0.301226.726.726.727.1
  -1.31%-0.30-0.300126.72726.727.1
  -1.31%-0.30-0.3-10126.7026.727.1
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章